Filing search / Inhibrx Biosciences, Inc. / "Environmental"

DEFM14A

INBX Inhibrx Biosciences, Inc.

26 Apr 24

Proxy related to merger

4:06pm

on regulatory approvals and macroeconomic and other environmental circumstances that may or may not occur in the future or may occur on longer … subsidiaries; the Company’s and its subsidiaries’ title to certain tangible and intangible assets; environmental matters of the Company and its

DEFA14A

INBX Inhibrx Biosciences, Inc.

23 Jan 24

Additional proxy soliciting materials

6:38am

3.17 Environmental Section 3.18 Suppliers Section 3.19 Anti-Corruption Section 3.20 Global Trade Control Laws Section 3.21 FDA and Related Matters … with respect to infringement, or misappropriation or other violation of the Intellectual Property rights of any third person. Section 3.17 Environmental

8-K

EX-2.1

INBX Inhibrx Biosciences, Inc.

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

3.17 Environmental Section 3.18 Suppliers Section 3.19 Anti-Corruption Section 3.20 Global Trade Control Laws Section 3.21 FDA and Related Matters … with respect to infringement, or misappropriation or other violation of the Intellectual Property rights of any third person. Section 3.17 Environmental

8-K

EX-2.2

INBX Inhibrx Biosciences, Inc.

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

. “Environmental Laws” has the meaning given to such term in the Merger Agreement. “ERISA” means the Employee Retirement Income Security Act of 1974. “Escrow … , or determined or determinable, including those arising under any Law (including Environmental Law), Proceeding, whether asserted or unasserted, or order

D

uu32femakx

31 Aug 23

$200.00 mm in equity / options / securities to be acquired, sold $200.00 mm, 5 investors

4:06pm

S-3ASR

EX-1.2

f4jyp99 2wdrv

3 Sep 21

Automatic shelf registration

4:22pm

10-K

s6hyqzfwcqw eu4

12 Mar 21

Annual report

8:46am

10-Q

z2h1d bsh9c782

13 Nov 20

Quarterly report

4:09pm

424B4

w4gqn7kbt 8o

19 Aug 20

Prospectus supplement with pricing info

5:21pm

DRS

uwp26s67iyc7

26 Jun 20

Draft registration statement

12:00am

D

82xjs9

16 Apr 20

$30M in equity / debt / options / securities to be acquired, sold $15M, 5 investors

12:00am

S-1

6vv5p

3 Jun 19

IPO registration

4:17pm

S-1

EX-10.19

ogvh56wgb5xc9i6saa

3 Jun 19

IPO registration

4:17pm